Compare
Itron, Inc. vs Teradyne, Inc vs Allient Inc vs Transcat Inc
| Latest fiscal year | Itron, Inc. ITRI | Teradyne, Inc TER | Allient Inc ALNT | Transcat Inc TRNS |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2026-03-28 |
| Revenue | $2.37B | $3.19B | $554.48M | $331.88M |
| Revenue growth (YoY) | -3.0% | +13.1% | +4.6% | +19.2% |
| Gross margin | 37.7% | 58.2% | 32.8% | 32.6% |
| Operating margin | 13.2% | 20.4% | 7.9% | 4.0% |
| Net margin | 12.7% | 17.4% | 4.0% | 1.6% |
| Net income | $301.06M | $554.05M | $22.03M | $5.38M |
| EPS (Diluted) | $6.50 | $3.47 | $1.32 | $0.57 |
| Operating cash flow | $405.95M | $674.41M | $56.67M | $34.85M |
| Free cash flow | $383.06M | $450.41M | $49.69M | $19.55M |
| Cash & equivalents | $1.02B | $293.75M | $40.70M | $4.94M |
| Total assets | $3.72B | $4.18B | $577.60M | $480.49M |
| Total liabilities | $1.98B | $1.39B | $276.14M | $179.87M |
| Shareholders' equity | $1.72B | $2.80B | $301.45M | $300.62M |
| Return on year-end equity | 17.5% | 19.8% | 7.3% | 1.8% |
| Shares outstanding | 44.93M | 156.09M | 16.94M | 9.33M |
Revenue, most recent five fiscal years
| Fiscal year | Itron, Inc. | Teradyne, Inc | Allient Inc | Transcat Inc |
|---|---|---|---|---|
| Latest | $2.37B Ended 2025-12-31 | $3.19B Ended 2025-12-31 | $554.48M Ended 2025-12-31 | $331.88M Ended 2026-03-28 |
| 1 year earlier | $2.44B Ended 2024-12-31 | $2.82B Ended 2024-12-31 | $529.97M Ended 2024-12-31 | $278.42M Ended 2025-03-29 |
| 2 years earlier | $2.17B Ended 2023-12-31 | $2.68B Ended 2023-12-31 | $578.63M Ended 2023-12-31 | $259.48M Ended 2024-03-30 |
| 3 years earlier | $1.80B Ended 2022-12-31 | $3.16B Ended 2022-12-31 | $502.99M Ended 2022-12-31 | $230.57M Ended 2023-03-25 |
| 4 years earlier | $1.98B Ended 2021-12-31 | $3.70B Ended 2021-12-31 | $403.52M Ended 2021-12-31 | $204.96M Ended 2022-03-26 |